Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: CIRSE Standards of Practice on Peri-operative Anticoagulation Management During Interventional Radiology Procedures.

Cardiovascular and interventional radiology·2026
Same author

Venous Thromboembolism and Testosterone Therapy in Klinefelter Syndrome.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2025
Same author

Reported particles are not blood clots, so anticoagulant drugs are not a plausible treatment.

Research and practice in thrombosis and haemostasis·2024
Same author

The thrombosis and haemostasis community network come face-to-face in a new (almost) post pandemic world.

Journal of thrombosis and haemostasis : JTH·2022
Same author

Education of healthcare professionals and the public about thrombosis and COVID-19.

Journal of thrombosis and haemostasis : JTH·2021
Same author

Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT).

Research and practice in thrombosis and haemostasis·2021
Same journal

HISTORY DOWN THE DRAIN.

Transactions of the Medical Society of London·2016
Same journal

BARIATRIC SURGERY--BELIEF, BIOLOGY OR BEHAVIOUR.

Transactions of the Medical Society of London·2016
Same journal

LORD MORAN AND WINSTON CHURCHILL DID THE PRCP HELP TO WIN THE WAR.

Transactions of the Medical Society of London·2016
Same journal

ON CRUSADERS ANCIENT AND MODERN THE ORDER OF ST JOHN.

Transactions of the Medical Society of London·2016
Same journal

MEDICINE, WAR AND CAPTIVITY: SOUTHEAST ASIA 1941-1945.

Transactions of the Medical Society of London·2016
Same journal

GYNAECOLOGICAL CANCER: GREAT PROGRESS FROM MY HEROES BUT IS IT TIME FOR A PARADIGM SHIFT?

Transactions of the Medical Society of London·2016
See all related articles

Related Experiment Video

Updated: May 28, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Avoiding clots. Thromboprophylaxis 2008.

Beverley Hunt1

  • 1Lifeblood.

Transactions of the Medical Society of London
|October 14, 2011
PubMed
Summary
This summary is machine-generated.

Despite having effective tools for thromboprophylaxis, implementation remains a challenge. Further guidelines and simpler anticoagulation methods are needed for widespread adoption in patient care.

Related Experiment Videos

Last Updated: May 28, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Area of Science:

  • Medical Science
  • Clinical Practice
  • Patient Safety

Background:

  • Effective thromboprophylaxis strategies exist.
  • There is a persistent failure in implementing these strategies.
  • The need for improved clinical practice guidelines is evident.

Purpose of the Study:

  • To highlight the gap between evidence and implementation in thromboprophylaxis.
  • To identify barriers to the successful application of thromboprophylaxis.
  • To emphasize the need for updated guidelines and simpler treatment options.

Main Methods:

  • Analysis of current thromboprophylaxis implementation.
  • Review of existing clinical practice and guidelines.
  • Assessment of potential improvements through new anticoagulants.

Main Results:

  • Excellent thromboprophylaxis tools were available in 2008.
  • Implementation of thromboprophylaxis continues to fail.
  • Awaiting mandates from implementation groups and updated NICE guidelines.
  • Newer oral anticoagulants may simplify delivery.

Conclusions:

  • There is a critical need to address the implementation gap in thromboprophylaxis.
  • Mandatory guidelines and simpler anticoagulation methods are crucial for improving patient outcomes.
  • Further research and policy changes are required to ensure effective thromboprophylaxis for all hospitalized patients.